The Economical Impact of Pain
Pain afflicts about 20% of adults globally. The source of pain ranges from a variety of health conditions, including arthritis, osteoarthritis, rheumatoid arthritis, migraine, fibromyalgia, back pain, cancer and chronic pain. Pain is very costly to society and individuals . It typically requires costly ongoing medical treatment and increases the costs of treating other health conditions. In addition to medical care costs, pain has indirect costs because it reduces labor market productivity through presenteeism and absenteeism. Workers with pain are sometimes unable to function at their full capabilities. Also, pain can cause workers to missed days or reduce their participation in the labor market from full-time- to part time or even drop out of the labor market altogether. Gaskin and Richard (J Pain 13(8):715–724, 2012, ) estimated the annual cost of chronic and persistent pain in the United States ranged from $560 to $635 billion in 2010. Gustavsson et al. (Eur J Pain, 2012, ) estimated that on average adults in Sweden incurred an annual costs of medical care due to chronic pain conditions of €2650 and loss annually €6429 in labor market productivity. This study reviews estimates of the costs of pain across a variety of countries and for several conditions that cause pain. The bottom line is pain regardless of the country or condition is costly.
KeywordsCosts of pain Labor market costs Direct medical care costs Individual costs Societal costs
The views expressed are those of the authors and do not necessarily reflect the official views of the Uniformed Services University of the Health Sciences or the U.S. Department of Defense.
- 2.Gustavsson A1, Bjorkman J, Ljungcrantz C, et al. (2012) Socio-economic burden of patients with a diagnosis related to chronic pain—register data of 840,000 Swedish patients. Eur J Pain. doi: 10.1016/j.ejpain.2011.07.006.
- 3.International Association for the Study of Pain: unrelieved pain is a major global healthcare problem. http://www.iasp-pain.org/PublicationsNews/PAIN.aspx?navItemNumber=570. Accessed 14 Oct 2015.
- 7.Munakata J, Hazard E, Serrano D, Klingman D, et al. Economic burden of transformed migraine: results from the American migraine prevalence and prevention (AMPP) study. Headache. 2009. doi: 10.1111/j.1526-4610.2009.01369.x.
- 8.Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results From the International Burden of Migraine Study (IBMS). Headache. 2011. doi: 10.1111/j.1526-4610.2011.01945.x.
- 9.White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008. doi: 10.1097/JOM.0b013e31815cff4b.
- 10.Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007. doi: 10.1111/j.1742-1241.2007.01480.x.
- 11.Kleinman N, Harnett J, Melkonian A, et al. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med. 2009. doi: 10.1097/JOM.0b013e3181bb808b.
- 12.Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013. doi: 10.1016/j.joca.2013.03.018.
- 13.Wier LM, Andrews RM (2011) The national hospital bill: the most expensive conditions by payer, 2008, HCUP Statistical Brief #107. Agency for Healthcare Research and Quality.Google Scholar
- 15.Kotlarz H, Gunnarsson CL, Fang H, et al. Osteoarthritis and absenteeism costs: evidence from US National survey data. J Occup Environ Med. 2010. doi: 10.1097/JOM.0b013e3181cf00aa.
- 16.Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res. 2012. doi: 10.1002/acr.21617.
- 17.Kavanaugh A. Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol. 2007. doi: 10.1016/j.berh.2007.05.005.
- 18.De Azevedo AV, Ferraz MB, Ciconelli RM. Indirect costs of rheumatoid arthritis in Brazil. Value Health. 2008. doi: 10.1111/j.1524-4733.2008.00332.x.
- 20.Neovius M, Simard JF, Askling J. How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? Ann Rheum Dis. 2011. doi: 10.1136/ard.2010.136812.